In prostate cancer, it downregulates epidermal growth factor receptor (EGFR) signaling, leading to cell cycle arrest and reduced expression of tumor growth factor (TGF-α) (Singh and Agarwal, 2004). The gene discussed is EGFR; the disease is Familial prostate cancer.